|1.||Wender, Paul A: 4 articles (10/2009 - 07/2005)|
|2.||Longcore, Kate E: 2 articles (10/2009 - 02/2007)|
|3.||Longcore, Kate: 2 articles (02/2006 - 07/2005)|
|4.||Salomon, A R: 2 articles (01/2001 - 12/2000)|
|5.||Voehringer, D W: 2 articles (01/2001 - 12/2000)|
|6.||Khosla, C: 2 articles (01/2001 - 12/2000)|
|7.||Herzenberg, L A: 2 articles (01/2001 - 12/2000)|
|8.||Zabriskie, T Mark: 1 article (02/2015)|
|9.||Mahmud, Taifo: 1 article (02/2015)|
|10.||Ishmael, Jane E: 1 article (02/2015)|
02/01/2015 - "We find the metabolic phenotype of the cell to be a critical determinant of apoptolidin sensitivity and the likely basis for cancer cell selectivity. "
01/30/2006 - "Apoptolidin is a natural product that selectively induces apoptosis in several cancer cell lines. "
07/07/2005 - "[reaction: see text] Apoptolidin (1) is a promising new therapeutic lead that exhibits remarkable selectivity against cancer cells relative to normal cells. "
02/16/2006 - "[structure: see text] Apoptolidin (1) exhibits potent and highly selective apoptosis inducing activity against sensitive cancer cell lines and is hypothesized to act by inhibition of mitochondrial F(0)F(1)-ATP synthase. "
12/19/2000 - "Inhibitors of both lactate formation and carbon flux through the Embden-Meyerhof pathway significantly sensitized apoptolidin-resistant tumors to this drug. "
10/01/2009 - "Biological evaluation of the new apoptolidin analogues was then conducted using growth inhibition assays based on the H292 human lung carcinoma cell line. "
02/15/2007 - "The isolation, characterization, and preliminary biological activity of apoptolidin D, a new apoptolidin that exhibits anti-proliferative activity against H292 human lung carcinoma cells at nanomolar concentrations, are reported. "
|3.||Melanoma (Melanoma, Malignant)
|5.||Lung Neoplasms (Lung Cancer)
|3.||Proton-Translocating ATPases (ATPase, H+)